处方质子抑制剂的模式:评估适当性和导致其不良影响的因素反应风险
Aymen A Alqurain1, Mohammed F Alomar2, Shatha Fakhreddin3
1Department of Clinical Practice, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia.
Journal of clinical medicine
|October 26, 2024
概括
质子抑制剂 (PPI) 的使用是常见的,但不适当的处方会增加药物不良反应的风险. 男性性别和更多的处方药物是PPI相关不良事件的关键风险因素.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 医疗保健服务研究 医疗服务研究
背景情况:
- 质子抑制剂 (PPI) 是一种被广泛处方的药物.
- 不适当的PPI使用与不良药物反应 (ADRs) 有关.
- 关于沙特阿拉伯东部地区的PPI处方模式和ADR风险因素的数据有限.
研究的目的:
- 评估使用PPI的流行率和使用模式.
- 确定导致PPI相关ADRs风险的因素.
- 评估沙特阿拉伯医疗保健机构的PPI处方.
主要方法:
- 电子医疗记录的回顾性,横截面研究 (2020年1月 - 2021年12月).
- 纳入标准:在门诊诊所的40岁以上的患者.
- 分类PPI剂量强度;用于识别ADR风险因素的后勤回归.
主要成果:
- 在41,084名患者中,31%的患者被处方PPI.
- 使用PPI的女性更有可能服用更多药物,并且不太可能患上胃炎.
- 高剂量的PPI使用与男性性别,年龄较大和多药性有关.
结论:
- 很大一部分患者接受PPI,可能会有不适当的处方.
- 男性性别和多药性与PPI相关的副作用的风险增加有关.
- 重新评估PPI处方对于优化治疗和最大限度地降低风险至关重要.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
360
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
360
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
542
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
542
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
407
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
407
Peptic Ulcer Disease I: Introduction
139
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
139


